Introduction: Mycoplasmas are bacteria commonly found in the commensal flora of humans and can occasionally be pathogenic. The population and the geographical area determine their susceptibility to various antibiotics. Methodology: We carried out a cross-sectional study from January to June 2022 at the Douala General Hospital. All women who were sexually active and willing to participate were included. Endo-cervical swabbing was used to collect the samples. Culture and antibiotic susceptibility testing were performed in a liquid medium using Mycoplasma-SystemPlus Gallery (Liofilchem). All samples that degraded urea (threshold > 103 for Ureaplasma urealyticum) and arginine (threshold > 104 for Mycoplasma hominis) were deemed positive. Results: A total of 107 women with a median age of 33 ± 8.3 years and a predominance of 30-40 years (41.1%) were included. The frequency of mycoplasma infection was 73.8% with 34.1%, 11.4% and 54.4% for Ureaplasma urealyticum, Mycoplasma hominis and co-infection respectively. Resistance rates to Minocycline were low, 1.3% for Ureaplasma urealyticum and 3.7% for co-infection; for Pefloxacin the resistance rates were 3.7% (Ureaplasma urealyticum, Mycoplasma hominis) and 22.8% (co-infection). Ureaplasma urealyticum had a resistance rate of 3.7% for Erythromycin, 1.3% for Clarithromycin and 5% for Azithromycin. There was no significant correlation between risk factors and infection. Vaginal cleansing and the development of resistance in mycoplasma infection were found to be significantly correlated (OR = 6.915 [1.52 - 31.55]; (p = 0.013)). Conclusion: Minocycline was the most active antibiotic and Ureaplasma urealyticum was the species with the lowest rate of resistance. Antibiotic resistance was more common in co-infected people than mono-infected. Antibiotic resistance was independently correlated with vaginal douching.
References
[1]
Andrzejczak-Grządko, S. and Dolińska, I. (2019) Detection of Urogenital Mycoplasmas in Clinical Samples. Postepy Biochemii, 65, 299-305.
[2]
Kouassi-Agbessi, T.B., Cablan, A.M., Krizo, A.G., Zinzendorf, N.Y. and Amin, C.N.C. (2019) Study of Antibiotic Susceptibility of Mycoplasmas Isolated from Semen in Abidjan. International Journal of Biological and Chemical Sciences, 13, 1558-1564. https://doi.org/10.4314/ijbcs.v13i3.28
[3]
Lis, R., Rowhani-Rahbar, A. and Manhart, L.E. (2015) Mycoplasma Genitalium Infection and Female Reproductive Tract Disease: A Meta-Analysis. Clinical Infectious Diseases, 61, 418-426. https://doi.org/10.1093/cid/civ312
[4]
Jensen, J.S., Cusini, S., Gomberg, M., Moi, H., Wilson, J. and Unemo M. (2022) 2021 European Guideline on the Management of Mycoplasma genitalium Infections. Journal of the European Academy of Dermatology and Venereology, 36, 641-650. https://doi.org/10.1111/jdv.17972
[5]
Leli, C., Mencacci, A., Bombaci, J.C., D’Alò, F., Farinelli, S., Vitali, M. and Bistoni, F. (2012) Prevalence and Antimicrobial Susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a Population of Italian and Immigrant Outpatients. Le Infezioni in Medicina, 20, 82-87.
[6]
Zhu, X., Li, M., Cao, H., Yang, X. and Zhang, C. (2016) Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the Semen of Male Outpatients with Reproductive Disorders. Experimental and Therapeutic Medicine, 12, 1165-1170. https://doi.org/10.3892/etm.2016.3409
[7]
Karou, S.D., Djigma, F., Sagna, T., Nadembega, C., Zeba, M., Kabre, A. and Simpore, J. (2012) Antimicrobial Resistance of Abnormal Vaginal Discharges Microorganisms in Ouagadougou, Burkina Faso. Asian Pacific Journal of Tropical Biomedicine, 2, 294-297. https://doi.org/10.1016/S2221-1691(12)60025-2
[8]
Gandji, S., Bankolé, H.S., Dougnon, T.V., Da Silva, J., Zannou, C. and Biaou, O. (2013) Occurrence of Tubal Obstructions in Women in Cotonou (Benin): Role of Bacteria. International Journal of Biological and Chemical Sciences, 7, 1338-1343. https://doi.org/10.4314/ijbcs.v7i3.39
[9]
Gonsu, H.K. (2014) Prevalence of Mycoplasma hominis and Ureaplasma urealyticum among Women Infected with HIV in Yaoundé-Cameroon. International Journal of Infectious Diseases, 21, 333. https://doi.org/10.1016/j.ijid.2014.03.1108
[10]
Longdoh, N.A., Gregory, H.E.E., Djeumako, W.A., Nguedia, A.J.C., Francois-Xavier, M.K. and Tebit, K.E. (2018) The Occurrence and Antimicrobial Susceptibility Patterns of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women in Three District Hospitals in Douala, Cameroon. Journal of Advances in Medicine and Medical Research, 27, 1-11. https://doi.org/10.9734/JAMMR/2018/43356
[11]
Njunda, A.L., Nsagha, D.S., Assob, J.C., Palle, J.N., Kamga, H.L., Nde, P.F. and Weledji, P.E. (2011) Genital Mycoplasmas in Women Attending the Yaoundé University Teaching Hospital in Cameroon. Journal of Public Health in Africa, 2, e16.
[12]
Waites, K.B., Duffy, L.B., Bébéar, C.M., Matlow, A., Talkington, D.F., Kenny, G.E. and Brown, S.D. (2012) Standardized Methods and Quality Control Limits for Agar and Broth Microdilution Susceptibility Testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. Journal of Clinical Microbiology, 50, 3542-3547. https://doi.org/10.1128/JCM.01439-12
[13]
Mihai, M., Valentin, N., Bogdan, D., Carmen, C.M., Coralia, B. and Demetra, S. (2011) Antibiotic Susceptibility Profiles of Mycoplasma hominis and Ureaplasma urealyticum Isolated during a Population-Based Study Concerning Women Infertility in Northeast Romania. Brazilian Journal of Microbiology, 42, 256-260. https://doi.org/10.1590/S1517-83822011000100032
[14]
Bartolini, A., Scapaticci, M., Akkouche, W., Boldrin, C. and Rossi, L. (2017) Prevalence and Antimicrobial Susceptibility of Genital Mycoplasmas Detected by Mycoplasma IST 2 from Urogenital Samples in Padua, Italy, Between January 2014 and December 2015. Microbiologia Medica, 32, Article No. 6503. https://doi.org/10.4081/mm.2017.6503
[15]
Schneider, S.C., Tinguely, R., Droz, S., Hilty, M., Donà, V., Bodmer, T. and Endimiani, A. (2015) Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland. Antimicrobial Agents and Chemotherapy, 59, 6026-6031. https://doi.org/10.1128/AAC.00895-15
[16]
Guindo, I. (2022) Antibiotic Resistance Profile of Mycoplasma hominis and Ureaplasma urealyticum Identified in Women in Bamako, Mali. Revue Malienne d’Infectio-logie et de Microbiologie, 17, 32-37. https://doi.org/10.53597/remim.v17i1.2234
[17]
Tebeu, P.M., Belinga, E., Sama, J.D., Kenmogne, S.A., Tchente, C. and Sandjong, I. (2020) Epidemiological, Clinical and Therapeutic Aspects of Acute Pelvic Pain in Women at the Yaoundé Gyneco-Obstetric and Pediatric Hospital (HGOPY). The Pan African Medical Journal, 35, Article No. 16. https://doi.org/10.11604/pamj.2020.35.16.14332
[18]
Bolti, M.A., Alio, H.M., Yakhoub, M.A., NadjiAdjim, N., Akouya, S.D., Allah-Siyangar, N. and Djerabe, N. (2022) Epidemiological Profile of Mycoplasma hominis and Ureaplasma urealyticum Mycoplasmas at the University of N’Djamena Teaching Hospital (CHU-R). British Journal of Healthcare and Medical Research, 9, 88-97. https://doi.org/10.14738/jbemi.92.12119
[19]
Dessi, D., Margarita, V., Cocco, A., Marongiu, A., Fiori, P. and Rappelli, P. (2019) Trichomonas vaginalis and Mycoplasma hominis: New Tales of Two Old Friends. Parasitology, 146, 1150-1155. https://doi.org/10.1017/S0031182018002135
[20]
Wen, A., Srinivasan, U., Goldberg, D., Owen, J., Marrs, C.F., Misra, D., Wing, D.A., Ponnalur, S., Miles-Jay, A., Bucholz, B., Abbas, K. and Foxman, B. (2014) Selected Vaginal Bacteria and Risk of Preterm Birth: An Ecological Perspective. Journal of Infectious Diseases, 209, 1087-1094. https://doi.org/10.1093/infdis/jit632
[21]
Diop-N’diaye, H., Gueye, M., Camara, M., Gueye, S.B., Ba-Diallo, A., Karam, F. and Gaye-Diallo, A. (2014) Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum Isolated from the Genital Tract of Women in Dakar. Dakar Medical, 59, 177-184.
[22]
Díaz, L., Cabrera, L.E., Fernández, T., Ibáñez, I., Torres, Y., Obregón, Y. and Rivero, Y. (2013) Frequency and Antimicrobial Sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in Patients with Vaginal Discharge. MEDICC Review, 15, 45-47. https://doi.org/10.37757/MR2013V15.N4.11
[23]
Yeika, E.V., Ingelbeen, B., Kemah, B.L., Wirsiy, F.S., Fomengia, J.N. and Van der Sande, M.A. (2021) Comparative Assessment of the Prevalence, Practices and Factors Associated with Self-Medication with Antibiotics in Africa. Tropical Medicine & International Health, 26, 862-881. https://doi.org/10.1111/tmi.13600
[24]
Zhang, W., Li, L., Zhang, X., Fang, H., Chen, H. and Rong, C. (2021) Infection Prevalence and Antibiotic Resistance Levels in Ureaplasma urealyticum and Mycoplasma hominis in Gynecological Outpatients of a Tertiary Hospital in China from 2015 to 2018. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021, Article ID: 8842267. https://doi.org/10.1155/2021/8842267
[25]
Yıldırım, R., Vural, G. and Koçoğlu, E. (2020) Effect of Vaginal Douching on Vaginal Flora and Genital Infection. Journal of the Turkish German Gynecological Association, 21, 29-34. https://doi.org/10.4274/jtgga.galenos.2019.2018.0133
